Monday, August 31, 2020

Pear's Somryst precursor improved sleep health measures among patients with chronic insomnia and depressive symptoms

The new analysis of a Pear Therapeutics-based randomized controlled trial came along another investigation that spotted early signs of treatment dropout.

from Most Popular News from healthcareitnews.com https://ift.tt/2YREUsP
via IFTTT

0 comments:

Post a Comment